|Other names||W-2965-A; 5-Acetyltryptamine; 5-Acetyl-3-(2-aminoethyl)indole;|
|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||202.257 g·mol−1|
|3D model (JSmol)|
Acetryptine (INN) (developmental code name W-2965-A), also known as 5-acetyltryptamine (5-AT), is a drug described as an antihypertensive agent which was never marketed. Structurally, acetryptine is a substituted tryptamine, and is closely related to other substituted tryptamines like serotonin (5-hydroxytryptamine). It was developed in the early 1960s. The binding of acetryptine to serotonin receptors does not seem to have been well-investigated, although it was assessed at the 5-HT1A and 5-HT1D receptors and found to bind to them with high affinity. The drug may also act as a monoamine oxidase inhibitor (MAOI); specifically, as an inhibitor of MAO-A.